New Delhi: A law that stops the next generation from buying cigarettes may look like the ultimate tobacco control victory. But a growing body of scientific opinion argues that such policies, while politically attractive, could take decades to deliver meaningful health gains unless governments also tackle the millions of adults who are already addicted to smoking.
That debate has acquired fresh urgency as governments experiment with increasingly aggressive tobacco control policies. The UK has enacted landmark legislation to create a “smoke-free generation”, permanently barring the sale of tobacco to people born after January 1, 2009. New Zealand briefly pursued a similar generational ban before reversing course, while countries such as the US and Australia have tightened regulations on tobacco and nicotine products through taxation, flavour restrictions and public health campaigns.
Singapore has long maintained one of the world’s toughest anti-smoking regimes, combining high taxes with strict advertising and public smoking curbs. Against this backdrop, a new international analysis argues that the global fight against tobacco risks confusing prevention with elimination, unless equal attention is paid to helping today’s smokers quit.
Published online in The Lancet, the report, Beyond A Smoke-free Generation: Ending Smoking Within A Generation, contends that protecting future generations from cigarettes should not overshadow the immediate challenge of helping existing smokers quit. The authors argue that the goal should be nothing less than reducing adult smoking prevalence to “5% or below” as quickly as possible.
“Creating a smoke-free generation and ending smoking within a generation have different objectives. The former aims to prevent smoking initiation in future cohorts; the latter requires accelerated declines among adults who smoke with the aim of reaching a smoking prevalence of 5% or less as soon as possible,” says the paper.
The distinction matters for countries such as India, where the tobacco burden is measured not only in future risks but also in the lives being lost today. According to the World Health Organization, tobacco accounts for nearly 1.35 million deaths in India every year, while around 267 million adults use tobacco in one form or another. Smokeless tobacco remains the dominant product, adding a uniquely Indian dimension to the global tobacco challenge.
India’s Tobacco Reality
India has spent decades building one of the world’s strongest tobacco control frameworks. Public smoking bans, graphic health warnings, restrictions on advertising and periodic tax increases have all contributed to a gradual decline in tobacco use. More recently, the government approved higher excise duties on cigarettes to keep them less affordable.
Yet the numbers remain daunting. Tobacco use extends far beyond cigarettes to bidis, khaini, gutkha and other smokeless products deeply embedded in social and economic life. National surveys suggest that tobacco use has declined over time, but millions of users continue to face elevated risks of cancer, cardiovascular disease and chronic respiratory illnesses.
The Lancet paper argues that conventional tobacco control measures, while essential, have limits. “Policy adoption does not ensure impact on prevalence; the effect of FCTC MPOWER measures depends on enforcement, affordability, industry interference, markets, and tobacco revenue. Global implementation of the measures is uneven.”
For India, that observation carries particular significance. The country has made progress under the WHO Framework Convention on Tobacco Control, but enforcement varies across states and the challenge extends to regulating an enormous smokeless tobacco market. The economic stakes are equally high because India is among the world’s largest producers and consumers of tobacco.
The authors believe that tobacco control policy should focus on reducing the harm caused by combustible tobacco among people already smoking. “If the aim is to end the smoking epidemic rather than defer its conclusion, global tobacco control policy must prioritise the rapid replacement of cigarettes by less harmful nicotine alternatives for adults at greatest risk of tobacco harms, including socio-economically disadvantaged populations, indigenous peoples, and men in low- and middle-income countries (LMICs).”
That argument is likely to spark debate in India, where electronic nicotine products remain heavily restricted and policymakers have traditionally adopted a precautionary approach. Public health experts have expressed concerns over youth addiction and aggressive marketing, while harm reduction advocates argue that lower-risk alternatives could help established smokers quit combustible tobacco.
The Next Frontier
The Lancet commentary does not call for abandoning traditional tobacco control. Instead, it argues for a broader strategy that combines prevention, regulation and harm reduction.
“Ending smoking within a generation requires all three WHO Framework Convention on Tobacco Control (FCTC) strategies: demand reduction, supply reduction, and harm reduction. Prevention of youth smoking remains essential but must not divert attention away from the urgent task of reducing harm among people already exposed to combustible tobacco.”
The authors, Ruth Bonita and Robert Beaglehole of the University of Auckland, make a case for what they describe as risk-proportionate regulation, with the strictest controls reserved for cigarettes and other combustible tobacco products while safeguarding young people from nicotine addiction.
One of the paper’s most striking observations is: “People smoke for nicotine but die from the smoke.” The authors argue that tobacco control has concentrated heavily on reducing demand and supply while neglecting harm reduction, despite its inclusion in the WHO Framework Convention on Tobacco Control.
For India, the implications are profound. The country faces the dual challenge of protecting its vast youth population from nicotine addiction while reducing the health burden among millions of existing tobacco users. With tobacco-linked diseases placing enormous pressure on the healthcare system and productivity, the debate is shifting from whether smoking should end to how quickly that goal can realistically be achieved.
The UK’s smoke-free generation law may become a defining public health experiment. But the Lancet authors suggest that history will judge success not by how many future smokers are prevented, but by how many current smokers are helped to escape a habit that continues to kill millions.
(Cover photo by Mathew MacQuarrie on Unsplash)